The Rhizen Journey!
Our Journey To Be A Leading Oncology-focused Specialty Company Developing Differentiated Products Through Cutting-edge Science and Strategic Partnerships Started in 2008.
Novel programs targeting multiple hallmarks of cancer
Assessing the safety and efficacy of our novel pipeline
Accumulated from dedicated research efforts for the last 12 years
We Are All In To Make It Possible
OUR PARTNERING STRATEGY
Flexible Global and Regional Approach
In-license differentiated assets for development and commercialization
Build a pipeline of specialty assets across the oncology and onco-inflammation space